Service provider selection decisions are not made in a vacuum. In addition to the role that PPAs play in the process, companies also seek assistance from specialized outside consultants to help with their outsourcing decisions. One-third of respondents said they look to outside consultants for guidance with outsourcing their Phase II/III clinical development programs. When looking at company size, a slightly higher proportion of mid-size sponsors engage consultants.

Find more data from our latest Phase II/III Benchmarking study in our report Phase II/III CRO Benchmarking (12th Ed.)

Originally published in Life Science Leader.

View File